Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 13.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- Cambridge Antibody

23 May 2006 15:17

Franklin Resources Inc23 May 2006 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing (Note 1) Franklin Resources, Inc. Company dealt in Cambridge Antibody Technology Group Plc Class of relevant securityto which the dealings being disclosed relate (Note 2) Ordinary Date of dealing May 22, 2006 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 2,262,787 4.25%(2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total 2,262,787 4.25% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) Sale 4,960 12.960 GBP (b) Derivatives transactions (other than options) Product name, Long/short Number of securities Price per unit e.g. CFD (Note 6) (Note 7) (Note 5) (c) Options transactions in respect of existing securities(i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Option moneyname, selling, securities price American, date paid/e.g. purchasing, to which European received call varying etc. the option etc. per unit option relates (Note 5) (Note 7) (ii) Exercising Product name, e.g. Number of securities Exercise price per unit call option (Note 5) (d) Other dealings (including new securities)(Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. None stated. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure May 23, 2006 Contact name Lori A. Weber Telephone number 954-847-2283 If a connected EFM, name of offeree/offeror with which connected N/A If a connected EFM, state nature of connection (Note 10) N/A Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
16th May 200612:41 pmRNSEPT Disclosure
16th May 200612:17 pmRNSEPT Disclosure
16th May 200611:42 amRNSEPT Disclosure
16th May 200610:45 amRNSRule 8.3- Cambridge Antibody
15th May 20062:56 pmRNSRule 8.3- Cambridge Antibody
15th May 20067:03 amRNSOffer for Cambridge Antibody
15th May 20067:03 amRNSStatement
13th Apr 200610:03 amRNSBlocklisting Interim Review
13th Apr 200610:00 amRNSBlocklisting Interim Review
13th Apr 200610:00 amRNSBlocklisting Interim Review
13th Apr 20069:52 amRNSBlocklisting Interim Review
7th Apr 20061:12 pmRNSHolding(s) in Company
6th Mar 200611:03 amRNS20-F filing
3rd Mar 200611:07 amRNSHolding(s) in Company
9th Feb 20065:23 pmRNSDirector/PDMR Shareholding
9th Feb 200610:49 amRNSDirector/PDMR Shareholding
6th Feb 20067:01 amRNS1st Quarter Results
3rd Feb 20063:30 pmRNSAGM Statement
3rd Feb 20061:00 pmRNSRe: Q1 2006 Statement
31st Jan 20069:22 amRNSNotice of Results
25th Jan 20063:01 pmRNSSales update
3rd Jan 200610:18 amRNSAdditional Listing
3rd Jan 20067:00 amRNSDirector/PDMR Shareholding
23rd Dec 200510:00 amRNSCAT Annual Report sent to FSA
20th Dec 20053:32 pmRNSHolding(s) in Company
20th Dec 20053:29 pmRNSDirector/PDMR Shareholding
5th Dec 200511:23 amRNSDirector/PDMR Shareholding
1st Dec 20053:36 pmRNSDirector/PDMR Shareholding
28th Nov 20054:11 pmRNSDirector/PDMR Shareholding
28th Nov 20057:02 amRNSFinal Results
25th Nov 20053:33 pmRNSDirector/PDMR Shareholding
1st Nov 20057:01 amRNSProduct Candidate Acquisition
27th Oct 20053:46 pmRNSNotice of Results
26th Oct 20057:01 amRNSCAT & ABBOTT AGREE ROYALTIES
12th Oct 20055:12 pmRNSHolding(s) in Company
5th Oct 20053:30 pmRNSResearch Update
30th Sep 20052:55 pmRNSBlocklisting Interim Review
30th Sep 20052:52 pmRNSBlocklisting Interim Review
30th Sep 20052:46 pmRNSBlocklisting Interim Review
23rd Sep 20054:34 pmRNSHolding(s) in Company
15th Sep 20054:19 pmRNSDirector/PDMR Shareholding
12th Sep 20057:01 amRNSDirectorate Change
12th Sep 20057:01 amRNS3rd Quarter Results
19th Aug 20059:39 amRNSHolding(s) in Company
18th Aug 200510:01 amRNSHolding(s) in Company
15th Aug 200510:17 amRNSNotice of Results
23rd Jun 20057:01 amRNSCAT-354 Clinical Update
1st Jun 20055:20 pmRNSHolding(s) in Company
20th May 20058:00 amRNSUpdate re Abbott
19th May 200512:31 pmRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.